NCT07298109 Diaphragmatic Release for Low Back Pain
| NCT ID | NCT07298109 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karabuk University |
| Condition | Low Back Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2025-12-11 |
| Primary Completion | 2026-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2025-12-11 with a primary completion date of 2026-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Low back pain is one of the most common musculoskeletal disorders, significantly affecting the quality of life of individuals. In non-specific low back pain, a lack of stabilization in the core region negatively impacts the performance of activities. The diaphragm forms the framework of the core region, and its dysfunction can contribute to both respiratory problems and low back pain. This study will investigate the effects of diaphragm relaxation, added to spinal stabilization exercises, on pain, disability, quality of life, central sensitization, and trunk muscle endurance.
Eligibility Criteria
Inclusion Criteria: * Being between 18-65 years of age * Having been diagnosed with chronic non-specific lower back pain (pain between the gluteal folds and the 12th ribs lasting at least 12 weeks and without a known pathoanatomical cause) * Being willing to participate in the study Exclusion Criteria: * Psychological disorders, mental disorders, cancer, and severe depression * History of primary or metastatic spinal malignancy or spinal fracture * Neurological disease (Hemiplegia, Multiple Sclerosis, Parkinson's, etc.) * Having been diagnosed with advanced osteoporosis * Having undergone previous surgery or had an acute infection in the lumbar region
Contact & Investigator
Musa Güneş, PhD
PRINCIPAL INVESTIGATOR
Karabuk University
Frequently Asked Questions
Who can join the NCT07298109 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07298109 currently recruiting?
Yes, NCT07298109 is actively recruiting participants. Contact the research team at musagunes@karabuk.edu.tr for enrollment information.
Where is the NCT07298109 trial being conducted?
This trial is being conducted at Karabük, Turkey (Türkiye).
Who is sponsoring the NCT07298109 clinical trial?
NCT07298109 is sponsored by Karabuk University. The principal investigator is Musa Güneş, PhD at Karabuk University. The trial plans to enroll 42 participants.